Related Experiment Video
Updated: Jun 21, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune
Sara Zahraeifard1, Zhiguang Xiao1, Jae Young So1
1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Abstract:
Low response rate, treatment relapse, and resistance remain key challenges for cancer treatment with immune checkpoint blockade (ICB). Here we report that loss of specific tumor suppressors (TS) induces an inflammatory response and promotes an immune suppressive tumor microenvironment. Importantly, low expression of these TSs is associated with a higher expression of immune checkpoint inhibitory mediators. Here we identify, by using in vivo CRISPR/Cas9 based loss-of-function screening, that NF1, TSC1, and TGF-β RII as TSs regulating immune composition. Loss of each of these three TSs leads to alterations in chromatin accessibility and enhances IL6-JAK3-STAT3/6 inflammatory pathways. This results in an immune suppressive landscape, characterized by increased numbers of LAG3+ CD8 and CD4 T cells. ICB targeting LAG3 and PD-L1 simultaneously inhibits metastatic progression in preclinical triple negative breast cancer (TNBC) mouse models of NF1-, TSC1- or TGF-β RII- deficient tumors. Our study thus reveals a role of TSs in regulating metastasis via non-cell-autonomous modulation of the immune compartment and provides proof-of-principle for ICB targeting LAG3 for patients with NF1-, TSC1- or TGF-β RII-inactivated cancers.
Insights
Loss of tumor suppressors (TS) creates an immune-suppressive tumor microenvironment, hindering cancer immunotherapy. Targeting immune checkpoints like LAG3 offers a new strategy for treating cancers with inactivated TS.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Immune checkpoint blockade (ICB) faces challenges with low response rates, relapse, and resistance in cancer treatment.
- Loss of tumor suppressors (TS) can promote an immune-suppressive tumor microenvironment and is linked to increased immune checkpoint inhibitor expression.
Purpose of the Study:
- To identify tumor suppressors that regulate the immune microenvironment and immune checkpoint mediator expression.
- To investigate the therapeutic potential of targeting specific immune checkpoints in tumors with inactivated tumor suppressors.
Main Methods:
- Utilized in vivo CRISPR/Cas9 loss-of-function screening to identify key tumor suppressors.
- Analyzed chromatin accessibility and inflammatory pathways (IL6-JAK3-STAT3/6) upon TS loss.
- Assessed the efficacy of combined LAG3 and PD-L1 blockade in preclinical triple-negative breast cancer (TNBC) models.
Main Results:
- Identified NF1, TSC1, and TGF-β RII as tumor suppressors regulating immune composition.
- Loss of these TSs alters chromatin accessibility, enhances inflammatory pathways, and promotes an immune-suppressive landscape with increased LAG3+ T cells.
- Simultaneous blockade of LAG3 and PD-L1 inhibited metastasis in preclinical models of NF1-, TSC1-, or TGF-β RII-deficient TNBC.
Conclusions:
- Tumor suppressors play a critical role in modulating the immune compartment and metastasis through non-cell-autonomous mechanisms.
- Targeting LAG3, in combination with PD-L1, presents a promising therapeutic strategy for patients with cancers harboring inactivated NF1, TSC1, or TGF-β RII.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

